Gene · 7306
Papers3,635
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 3,635
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Tape-Strip Proteomic Analysis of Female Melasma Skin Lesions in a Chinese Population. | Clin Cosmet Investig Dermatol | 2025 | 40963885 | PubTator, text mining | PubMed |
| Metabolic Regulation of Biosynthesis of Melanin Nanoparticles for Enhancing Photothermal Therapy of Breast Tumor. | Small | 2025 | 40955865 | PubTator, text mining | PubMed |
| Tumour Single-Cell Bioinformatics: From Immune Profiling to Molecular Dynamics. | J Cell Mol Med | 2025 | 40954554 | PubTator, text mining | PubMed |
| Rare phenotypes of white coat color in Simmental calves: genetic causes of syndromic forms of albinism and depigmentation. | Mol Genet Genomics | 2025 | 40913728 | PubTator, text mining | PubMed |
| Genomic resistance in historical clinical isolates increased in frequency and mobility after the age of antibiotics. | Microb Genom | 2025 | 40889132 | PubTator, text mining | PubMed |
| Repurposing the Antibiotic D-Cycloserine for the Treatment of Hyperpigmentation: Therapeutic Potential and Mechanistic Insights. | Int J Mol Sci | 2025 | 40869042 | PubTator, text mining | PubMed |
| Natural protection against oxidative stress in human skin melanocytes. | Commun Biol | 2025 | 40858814 | PubTator, text mining | PubMed |
| Natural dual inhibitor isorhamnetin-3-O-neohespeidoside targets tyrosinase and MC1R for skin pigmentation management. | Sci Rep | 2025 | 40841385 | PubTator, text mining | PubMed |
| The Use of Medium-Deep Peelings to Treat Melasma: A Case Series Study. | J Cosmet Dermatol | 2025 | 40820687 | PubTator, text mining | PubMed |
| Association between Ki-67 and clinical outcomes in 324 Chinese patients with resectable acral melanoma. | Sci Rep | 2025 | 40820223 | PubTator, text mining | PubMed |
| Bioinformatics-based prognostic value and in vitro functional validation of PTK6 in cutaneous melanoma. | Front Oncol | 2025 | 40809015 | PubTator, text mining | PubMed |
| Delineating Tissue-Specific Cell Identity of Oral Mucosa in Humans and Mice From a Single-Cell Perspective. | J Cell Mol Med | 2025 | 40751276 | PubTator, text mining | PubMed |
| Biocompatible exosomes derived from Pinctada martensii mucus for therapeutic melanin regulation via α-MSH/NF-κB/MITF pathway. | Regen Biomater | 2025 | 40747328 | PubTator, text mining | PubMed |
| Whole genome sequence of petroleum hydrocarbon degrading novel strain Microbacter sp. EMBS2025 isolated from Chilika Lake, Odisha, India. | Sci Rep | 2025 | 40745011 | PubTator, text mining | PubMed |
| Anti-melanogenic and Antioxidant Activities of Lactiplantibacillus plantarum Strains in Skin Cells via the CREB/MITF and Nrf2/HO-1 Pathways. | Probiotics Antimicrob Proteins | 2025 | 40736668 | PubTator, text mining | PubMed |
| A Novel Peel to Prevent Post-Inflammatory Hyperpigmentation After CO2 Resurfacing for Acne Scars. | J Cosmet Dermatol | 2025 | 40736045 | PubTator, text mining | PubMed |
| Topical application of Tea leaf-derived nanovesicles reduce melanogenesis by modulating the miR-828b/MYB4 axis: better permeability and therapeutic efficacy than conventional tea extracts. | Mater Today Bio | 2025 | 40735705 | PubTator, text mining | PubMed |
| Oculocutaneous albinism in a patient with an OCA2 variant: molecular and clinical insights. | Asian Biomed (Res Rev News) | 2025 | 40735666 | PubTator, text mining | PubMed |
| Sparse matrix factorization robust to sample sharing across GWASs reveals interpretable genetic components. | Am J Hum Genet | 2025 | 40730164 | PubTator, text mining | PubMed |
| Vitamin C as a probable inhibitor of tyrosinase (Tyr) and tyrosinase-related protein-1 (TRP-1) in human gingiva: An analytical study. | J Oral Maxillofac Pathol | 2025 | 40703841 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7306/papers?page=4